BRPI0508744A - sistema de retenção gástrica e processo para revestir um comprimido ou cápsula - Google Patents

sistema de retenção gástrica e processo para revestir um comprimido ou cápsula

Info

Publication number
BRPI0508744A
BRPI0508744A BRPI0508744-9A BRPI0508744A BRPI0508744A BR PI0508744 A BRPI0508744 A BR PI0508744A BR PI0508744 A BRPI0508744 A BR PI0508744A BR PI0508744 A BRPI0508744 A BR PI0508744A
Authority
BR
Brazil
Prior art keywords
coating
capsule
tablet
retention system
gastric retention
Prior art date
Application number
BRPI0508744-9A
Other languages
English (en)
Inventor
Nitin Bhalachand Dharmadhikari
Yashoraj Rupsinh Zala
Original Assignee
Sun Pharmaceutical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind Ltd filed Critical Sun Pharmaceutical Ind Ltd
Publication of BRPI0508744A publication Critical patent/BRPI0508744A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F5/003—Implantable devices or invasive measures inflatable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F5/0036—Intragastrical devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nursing (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SISTEMA DE RETENçãO GáSTRICA E PROCESSO PARA REVESTIR UM COMPRIMIDO OU CáPSULA A presente invenção apresenta um novo sistema de retenção gástrica na forma de comprimido ou cápsula recobertos com um revestimentos expansível, mais particularmente, com um revestimento expansível que compreende um polímero formador de película e um componente expansível.
BRPI0508744-9A 2004-03-25 2005-03-24 sistema de retenção gástrica e processo para revestir um comprimido ou cápsula BRPI0508744A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN364MU2004 2004-03-25
IN1058MU2004 2004-10-07
PCT/IN2005/000091 WO2005101983A2 (en) 2004-03-25 2005-03-24 Gastric retention system

Publications (1)

Publication Number Publication Date
BRPI0508744A true BRPI0508744A (pt) 2007-08-14

Family

ID=35197425

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0508744-9A BRPI0508744A (pt) 2004-03-25 2005-03-24 sistema de retenção gástrica e processo para revestir um comprimido ou cápsula

Country Status (22)

Country Link
US (1) US9439851B2 (pt)
EP (1) EP1732522B1 (pt)
JP (1) JP5166018B2 (pt)
KR (1) KR101147666B1 (pt)
CN (1) CN1960711A (pt)
AP (1) AP2006003751A0 (pt)
AR (1) AR048331A1 (pt)
AU (1) AU2005235239B2 (pt)
BR (1) BRPI0508744A (pt)
CA (1) CA2561109C (pt)
EA (1) EA011151B1 (pt)
ES (1) ES2389729T3 (pt)
HK (1) HK1094422A1 (pt)
IL (1) IL178054A (pt)
MA (1) MA28542B1 (pt)
MX (1) MXPA06010678A (pt)
MY (1) MY148867A (pt)
NZ (1) NZ549853A (pt)
PE (1) PE20061160A1 (pt)
PL (1) PL1732522T3 (pt)
TW (1) TW200533391A (pt)
WO (1) WO2005101983A2 (pt)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7699863B2 (en) 2005-03-01 2010-04-20 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
US7785291B2 (en) 2005-03-01 2010-08-31 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
RU2433821C2 (ru) * 2005-08-30 2011-11-20 Пирамал Лайф Сайнсис Лимитед Фармацевтическая композиция метформина с длительным высвобождением и способ ее получения
US7674396B2 (en) * 2005-11-08 2010-03-09 Plensat Llc Method and system for treatment of eating disorders
AU2007201808B8 (en) * 2006-04-26 2013-09-05 Sun Pharmaceutical Advanced Research Company Ltd A method for alleviating signs and symptoms of spasticity
WO2007136735A2 (en) 2006-05-18 2007-11-29 Tulip Medical Ltd. Bioerodible self-deployable intragastric and non-gastric implants
US8765178B2 (en) 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods
WO2008039186A2 (en) * 2006-09-26 2008-04-03 Plensat, Llc Method and system for treatment of eating disorders
WO2008073282A2 (en) * 2006-12-07 2008-06-19 Schering Corporation Ph sensitive matrix formulation
KR20080076382A (ko) * 2007-02-15 2008-08-20 (주)아모레퍼시픽 실로스타졸의 제어방출 제제 및 그 제조방법
MX2010001071A (es) * 2007-07-27 2010-03-09 Depomed Inc Formas de dosificacion retentivas gastricas pulsatiles.
MX2010001629A (es) * 2007-08-10 2010-08-09 Alessandro Sannino Hidrogeles de polimero y metodos de preparacion de los mismos.
US20110171275A1 (en) * 2007-08-20 2011-07-14 Team Academy Of Pharmaceutical Science Gastroretentive drug delivery system, preparation method and use thereof
CN102202656A (zh) * 2008-08-15 2011-09-28 蒂宝制药公司 治疗和预防cns障碍的胃滞留药用组合物
JP2012500230A (ja) * 2008-08-18 2012-01-05 北京天衡▲薬▼物研究院 胃内滞留薬物放出システム及びその製造方法と使用
FR2938431B1 (fr) 2008-11-14 2013-12-20 Debregeas Et Associes Pharma Nouvelle composition a base d'acide gamma-hydroxybutyrique
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
FR2949061B1 (fr) 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
JP2013519726A (ja) 2010-02-17 2013-05-30 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド バクロフェン療法に感受性の病状の治療方法
EP2389933A1 (en) * 2010-05-25 2011-11-30 Sanovel Ilac Sanayi ve Ticaret A.S. Controlled-Release Pregabalin Compositions
CA2808546C (en) 2010-08-18 2018-02-20 Evonik Roehm Gmbh Gastric resistant pharmaceutical or nutraceutical formulation comprising one or more salts of alginic acid
WO2012085656A2 (en) 2010-12-22 2012-06-28 Purdue Pharma L.P. Encased tamper resistant controlled release dosage forms
KR20140075807A (ko) 2010-12-23 2014-06-19 퍼듀 퍼머 엘피 탬퍼 저항성 고체 경구 투여 형태
US20130017264A1 (en) * 2011-07-15 2013-01-17 Piramal Life Sciences Limited Alginate tube drug delivery system and method therefor
EP2765998A1 (en) * 2011-10-11 2014-08-20 Ranbaxy Laboratories Limited A gastroretentive dosage system and process of preparation thereof
EP2858604B1 (en) 2012-06-07 2024-02-21 Epitomee Medical Ltd Expanded device
ES2600860T3 (es) * 2012-08-27 2017-02-13 Evonik Röhm Gmbh Composición farmacéutica o nutracéutica con característica de liberación retardada y con resistencia contra la influencia de etanol
SI2887925T1 (sl) * 2012-08-27 2017-06-30 Evonik Roehm Gmbh Na želodčne tekočine odporen farmacevtski ali nutracevtski sestavek z odpornostjo na vpliv etanola
MX2015010041A (es) 2013-02-05 2015-10-30 Purdue Pharma Lp Formulacion farmaceuticas resistentes a la alteracion.
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
EP3091962B1 (en) * 2013-12-05 2022-06-08 Epitomee Medical Ltd. Retentive devices and systems for in-situ release of pharmaceutical active agents
US9895318B2 (en) * 2014-02-17 2018-02-20 Evonik Roehm Gmbh Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol
KR101642193B1 (ko) * 2014-10-13 2016-07-25 씨제이헬스케어 주식회사 메트포르민 서방성 제제 및 그의 제조방법
EP3025709B1 (en) 2014-11-27 2020-09-30 Capsugel Belgium NV Dosage form articles for external mucosal applications
SI3302444T1 (sl) * 2015-06-05 2021-01-29 Evonik Operations Gmbh Farmacevtski ali nutracevtski sestavek z odpornostjo na vpliv etanola
EP3167879A1 (en) 2015-11-10 2017-05-17 Evonik Technochemie GmbH Gastric retention active delivery systems
US10737079B2 (en) * 2016-12-02 2020-08-11 Clexio Biosciences Ltd. Gastric residence system
IL250090B (en) 2017-01-12 2018-10-31 Melcap Systems Ltd A capsule is intended for ingestion by a subject and a system is intended for the digestive system
JP6823539B2 (ja) * 2017-05-26 2021-02-03 株式会社ファンケル 胃内滞留性錠剤
US10918597B2 (en) 2017-06-16 2021-02-16 Kashiv Specialty Pharmaceuticals, Llc Gastroretentive dosage forms for sustained drug delivery
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
FR3068039B1 (fr) 2017-06-22 2020-07-10 Jellynov Composition auto-moussante en milieu acide et procede de preparation
US10918511B2 (en) 2017-07-26 2021-02-16 Verily Life Sciences Llc Ingestible intragastric balloon
WO2019126215A1 (en) 2017-12-18 2019-06-27 Tris Pharma, Inc. Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
EP3740189A1 (en) 2017-12-18 2020-11-25 Tris Pharma, Inc. Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release
WO2019126214A1 (en) 2017-12-18 2019-06-27 Tris Pharma, Inc. Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pulse drug release
CN111405895B (zh) * 2017-12-29 2022-10-21 江苏恒瑞医药股份有限公司 一种控释药物组合物及其制备方法
US11911513B2 (en) 2018-05-23 2024-02-27 Shanghai Wd Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor
JP7125791B2 (ja) 2018-05-23 2022-08-25 シャンハイ ダブリュディー ファーマシューティカル カンパニー，リミティド 活性薬物成分の放出制御システムおよびその製造方法
CN114191307A (zh) 2020-09-17 2022-03-18 上海汉都医药科技有限公司 一种口腔滞留装置及其制备方法
EP4056172A1 (en) 2018-06-18 2022-09-14 Amneal Complex Products Research LLC Extended release compositions comprising pyridostigmine
FR3089224B1 (fr) * 2018-12-04 2020-12-11 Jellynov Composition auto-moussante en milieu acide et procédé de préparation
US11389398B2 (en) 2019-05-14 2022-07-19 Clexio Biosciences Ltd. Gastroretentive treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
CN113116846B (zh) * 2019-12-31 2024-03-19 广州玻思韬控释药业有限公司 胃滞留片
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3786813A (en) 1972-12-27 1974-01-22 Alza Corp Drug delivery device with self actuated mechanism for retaining device in selected area
US4207890A (en) 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
US4101650A (en) 1977-04-06 1978-07-18 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Pepstatin floating minicapsules
EP0205336B1 (en) 1985-06-11 1991-09-11 Teijin Limited Oral sustained release pharmaceutical preparation
JPS62195323A (ja) * 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
JPH0747534B2 (ja) 1986-06-02 1995-05-24 ロ−ラ−ジヤパン株式会社 錠 剤
IL87710A (en) 1987-09-18 1992-06-21 Ciba Geigy Ag Covered floating retard form for controlled release in gastric juice
GB8722306D0 (en) * 1987-09-22 1987-10-28 Aps Research Ltd Sustained-release formulation
IT1245890B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
DE4406424A1 (de) 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US5783212A (en) 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
IL130872A (en) 1997-01-14 2004-02-19 Lohmann Therapie Syst Lts Device for controlled release of active compounds in the connection of the stomach and intestines containing an expanding component
US5788987A (en) 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
SE9702533D0 (sv) 1997-07-01 1997-07-01 Astra Ab New oral formulation
IN186245B (pt) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6350470B1 (en) 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
DE19822278A1 (de) 1998-05-18 1999-12-02 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoff im Gastrointestinaltrakt mit verzögerter Pyloruspassage
FR2784583B1 (fr) 1998-10-16 2002-01-25 Synthelabo Composition pharmaceutique a residence gastrique et a liberation controlee
DE19850309A1 (de) 1998-10-30 2000-05-04 Lohmann Therapie Syst Lts Expandierbares gastroretensives Therapiesystem mit verlängerter Magenverweildauer
AU764469B2 (en) * 1999-01-29 2003-08-21 Disphar International B.V. Pharmaceutical compositions
WO2001010405A1 (en) 1999-08-04 2001-02-15 Ranbaxy Laboratories Limited Hydrodynamically balanced oral drug delivery system
FR2797185B1 (fr) 1999-08-06 2001-10-26 Galenix Dev Composition pharmaceutique flottante comprenant une phase active et une phase non active
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
EA200300046A1 (ru) * 2000-06-23 2003-10-30 Тева Фармасьютикал Индастриес Лтд. Быстро увеличивающаяся в объеме композиция для удерживания и контролированного выделения терапевтических агентов в желудке и лекарственные формы, включающие композицию
US20030008007A1 (en) 2001-04-23 2003-01-09 Jose Gutierrez-Rocca Release pharmaceutical construct for gastric retention
AU2002355686B2 (en) 2001-07-04 2007-11-29 Sun Pharmaceutical Industries Limited Gastric retention controlled drug delivery system
EP1416919A1 (en) 2001-07-17 2004-05-12 Teva Pharmaceutical Industries Ltd. Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate
IN191024B (pt) * 2001-09-25 2003-09-13 J B Chemicals And Pharmaceutic
CN1630513A (zh) 2002-02-04 2005-06-22 兰贝克赛实验室有限公司 流体动力平衡的以两相释放的口服药物输递系统
JP2003306428A (ja) 2002-04-17 2003-10-28 Zensei Yakuhin Kogyo Kk 服用性を改善した硬カプセル剤
KR20050083750A (ko) * 2002-10-11 2005-08-26 디포메드 디벨롭먼트 리미티드 위-체류성 레보도파 전달 형태

Also Published As

Publication number Publication date
MY148867A (en) 2013-06-14
PE20061160A1 (es) 2006-11-12
CA2561109C (en) 2012-09-18
KR101147666B1 (ko) 2012-05-22
EA011151B1 (ru) 2009-02-27
AU2005235239A1 (en) 2005-11-03
US20080107732A1 (en) 2008-05-08
EP1732522A2 (en) 2006-12-20
ES2389729T3 (es) 2012-10-30
JP2007530530A (ja) 2007-11-01
IL178054A0 (en) 2006-12-31
MA28542B1 (fr) 2007-04-03
NZ549853A (en) 2009-12-24
CA2561109A1 (en) 2005-11-03
WO2005101983A2 (en) 2005-11-03
PL1732522T3 (pl) 2012-12-31
JP5166018B2 (ja) 2013-03-21
MXPA06010678A (es) 2006-12-15
AP2006003751A0 (en) 2006-10-31
EP1732522B1 (en) 2012-07-04
EA200601771A1 (ru) 2007-02-27
HK1094422A1 (en) 2007-03-30
TW200533391A (en) 2005-10-16
KR20060126611A (ko) 2006-12-07
IL178054A (en) 2013-11-28
AR048331A1 (es) 2006-04-19
US9439851B2 (en) 2016-09-13
CN1960711A (zh) 2007-05-09
AU2005235239B2 (en) 2011-06-23
WO2005101983A3 (en) 2006-04-27

Similar Documents

Publication Publication Date Title
BRPI0508744A (pt) sistema de retenção gástrica e processo para revestir um comprimido ou cápsula
WO2007146231A3 (en) Solvent systems for coating medical devices
NO20092256L (no) Polymerdispersjoner inneholdende sterkt forgrenede polykarbonater
BRPI0600777A (pt) método e sistema para a criação, armazenamento, gerenciamento e consumo de dados especìficos de cultura
BRPI0511417A (pt) métodos para estabilizar rotacionalmente lentes de contato
AR058832A1 (es) Recubrimiento de desprendimiento que contiene polimeros termoplasticos
BRPI0815033A2 (pt) Processo para aplicar uma película revestida ou não revestida, e, lente.
BRPI0606380A2 (pt) tratamento de substratos para melhorar a aderência de tinta aos substratos
WO2006084641A3 (en) Immersion liquid, exposure apparatus, and exposure process
BR112017001335A2 (pt) sistema de revestimento de múltiplas camadas, método para formar um sistema de revestimento de múltiplas camadas e substrato revestido
MX2012001714A (es) Etiqueta colgante y montaje de etiqueta del producto, y metodo de uso.
TW200719891A (en) Film coated product
BRPI0620229A8 (pt) formulação
BRPI0610747A2 (pt) processo para o melhoramento da elasticidade de um sistema polimérico colorido, sistema polimérico colorido, uso de um sistema polimérico colorido, e, processo para a produção de susbstratos revestidos com um sistema polimérico
BRPI0815649A8 (pt) Revestimento
WO2009037600A3 (en) Solid substrate with surface bound molecules and methods for producing and using the same
BR112014005678A2 (pt) sistema de revestimento/selante, dispersão resinosa aquosa e método para eletrorrevestir um substrato eletricamente condutivo
BRPI0600265A (pt) métodos e sistema para a inspeção de componentes fabricados
BR112019023375A2 (pt) Acesso à portadora de uplink
ATE524082T1 (de) Festlegesystem
WO2012035046A3 (en) Polysaccharide coating with gel particles
NO20080221L (no) Cykloolefinkopolymer flaske med et skrapebestandig belegg
WO2008056254A3 (en) Element for signs, process and system for manufacturing it
BR112022019984A2 (pt) Revestimento para um dispositivo, método para formar este e dispositivo revestido
EA201190050A1 (ru) Композиция кветиапина

Legal Events

Date Code Title Description
B25C Requirement related to requested transfer of rights

Owner name: SUN PHARMACEUTICAL INDUSTRIES LTD. (IN)

Free format text: AFIM DE ATENDER A TRANSFERENCIA REQUERIDA ATRAVES DA PETICAO NO 018100009205/SP DE 17/03/2010, REAPRESENTE O DOCUMENTO DE CESSAO COM AS ASSINATURAS DO CEDENTE, CESSIONARIO E 2 (DUAS) TESTEMUNHAS NOTARIZADO E COM A DEVIDA LEGALIZACAO CONSULAR.

B25A Requested transfer of rights approved

Owner name: SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN)

Free format text: TRANSFERIDO DE: SUN PHARMACEUTICAL INDUSTRIES LIMITED

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2307 DE 24/03/2015.